FDA Lifts Hold on Human Trial of Stem Cell Treatment
Last week, FDA announced that it had lifted a hold on the world's first human test of a treatment derived from embryonic stem cells. Experts are calling the trial -- developed by Geron Corporation and UC-Irvine -- a turning point for health research, as it will provide the first look at safety and efficacy of embryonic stem cells.
- "Stem Cell Trial Wins Approval of F.D.A." (Pollack, New York Times, 7/30).
- "FDA Approves Geron's Groundbreaking Study of Embryonic Cells" (Johnson, Contra Costa Times, 7/30).